CLOV vs TBPH · rev $1.37B vs P/E 7.5, rev $18.8M
Clover Health Investments Corp (CLOV) versus Theravance Biopharma Inc (TBPH) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Theravance Biopharma Inc (TBPH) is a biotechnology company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported TBPH revenue for 2024-12-31 was $18.8M. Net income was -$15.5M. Revenue was up 11.2% from 2024-09-30 to 2024-12-31. TBPH currently screens at market cap $861.5M and trailing P/E 7.5.
CLOV currently screens at market cap $1.55B. TBPH currently screens at market cap $861.5M and trailing P/E 7.5.
Not investment advice. Open the CLOV and TBPH stock pages for the full models.
Not investment advice.